ClinicalTrials.gg
Not yet recruitingNCT07891273TWITCH FORCEUpdated Oct 23, 2026

Beyond Voluntary Effort: Reliability and Validity of Magnetic Femoral Nerve Stimulation for Assessing Quadriceps Strength in Critically Ill Patient

An interventional study of Magnetic Femoral Nerve Stimulation in Critical Illness and ICU-acquired Weakness, sponsored by Daniel Langer. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Daniel Langer · Not applicable, Interventional, and Other

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Intensive care unit-acquired weakness (ICU-AW) is a common complication of critical illness and can negatively affect recovery and long-term physical functioning. Early and reliable assessment of muscle strength is essential for detecting muscle weakness and monitoring changes during an intensive care unit (ICU) stay. However, conventional strength assessments, such as manual muscle testing, require voluntary muscle contractions, making them unsuitable for patients who are not yet cooperative and limiting the possibility of assessing muscle strength during the early stages of critical illness. Magnetic femoral nerve stimulation offers an alternative, non-volitional approach to assessing quadriceps muscle strength. Nevertheless, the reliability and validity of this technique in critically ill patients remain insufficiently established.

This prospective methodological study aims to investigate the reliability and convergent validity of quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation in critically ill patients.

A total of 33 cooperative adult patients admitted to medical or surgical ICUs will be included. Participants will undergo repeated quadriceps twitch force assessments over two consecutive days, performed by two assessors. Measurements will be conducted using a custom-developed frame designed to facilitate standardized quadriceps strength assessment at the bedside. Both single and paired magnetic stimulation techniques will be evaluated.

The primary outcome is the intra-rater reliability of paired twitch force measurements. Secondary outcomes include the inter-rater reliability of paired twitch force measurements, the intra-rater and inter-rater reliability of single twitch force measurements, and the convergent validity of twitch force measurements assessed through their association with maximal voluntary contraction force and potentiated twitch force. Reliability and agreement will be evaluated using intraclass correlation coefficients and complementary measurement error analyses.

Establishing these measurement properties could support objective, non-volitional muscle strength assessment in critically ill patients, including those unable to participate in conventional strength testing. This could facilitate early baseline strength assessment, longitudinal monitoring of muscle recovery, and the evaluation of interventions aimed at preventing or treating ICU-AW..

02

Conditions studied

  • Critical Illness
  • ICU-acquired Weakness

Browse trials for

Keywords

  • critical illness
  • ICU-acquired weakness
  • femoral nerve magnetic stimulation
  • quadriceps muscle strength
  • non-volitional muscle strength assessment
03

In context

Critical Illness

1,923 studies on the registry are indexed under Critical Illness; 465 are open to participants now.

This study's planned enrollment of 33 is below the median of 90 across 1,003 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

This is the only study on the registry with Daniel Langer as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary written informed consent of the participant has been obtained prior to the initiation of any study-related measurements
  • Adults (≥18 years)
  • Expected to remain in the ICU for more than an additional 2 days starting from study enrolment
  • Fully cooperative, as assessed daily during routine clinical care by ICU physiotherapists using five standardized commands ("open/close your eyes", "look at me", "open your mouth and stick out your tongue", "nod your head", and "raise your eyebrows when I have counted to 5")
  • Quadriceps muscle strength of at least 3/5 on the Medical Research Council (MRC) scale for knee extension.

Exclusion criteria

Exclusion Criteria:

  1. Medical instability A: Cardiorespiratory instability

    • Mean arterial pressure \< 60 mmHg or > 110 mmHg
    • Fraction of inspired oxygen (FiO₂) ≥ 60%
    • PaO₂/FiO₂ ratio \< 200
    • Respiratory rate > 30 breaths·min-¹ B: Neurological instability
    • Intracranial pressure > 20 mmHg
    • Cerebral perfusion pressure \< 70 mmHg C: Surgery within the past 24h D: Body temperature > 40
  2. Contraindications to magnetic stimulation A: Implanted metal or electronic devices, including

    • Lower limb prostheses
    • Internal and external fixation devices of the lower limb
    • Vascular stents
    • Cardiac pacemakers or defibrillators
    • Implanted nerve stimulators B: Lower limb structural, skin, or soft tissue conditions
    • Acute or chronic injuries
    • Wounds preventing supine positioning
    • Lower limb amputation C: Neuromuscular conditions
    • Pre-existing central or peripheral neuromuscular disorders
    • Neuromuscular blocking agents in the preceding 48h D: Morbid obesity (body mass index >35 kg/m2) E: Pregnancy
  3. Palliative care
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
33 participants (estimated)

Study arms

  • Experimental
    Magnetic Femoral Nerve Stimulation

    All participants will undergo quadriceps muscle strength assessments over two consecutive days, following the same standardized measurement sequence. On the first day, the first assessor will perform single and paired twitch force measurements using magnetic femoral nerve stimulation, alongside maximal voluntary contraction and potentiated twitch force assessments. On the second day, single and paired twitch force measurements will be repeated by the first assessor in the morning and by a second assessor in the afternoon to evaluate intra-rater and inter-rater reliability.

    Diagnostic Test: Magnetic Femoral Nerve Stimulation

Interventions

  • Diagnostic testMagnetic Femoral Nerve Stimulation

    Participants will be positioned prone in their hospital bed, with the knee flexed at approximately 90° using a dedicated measurement setup. A magnetic stimulation coil will be placed over the femoral nerve to elicit involuntary quadriceps muscle contractions. The resulting twitch force will be measured using a strain gauge dynamometer attached at the ankle. Stimulation intensity will be progressively increased to establish supramaximal stimulation, after which both single and paired magnetic stimuli will be applied to assess quadriceps twitch force.

06

What researchers measure

Primary outcomes

  1. Intra-rater reliability of paired quadriceps twitch force measurements

    Intra-rater reliability of paired quadriceps twitch force measurements will be assessed using the intraclass correlation coefficient (ICC) with 95% confidence intervals, comparing measurements performed by the same assessor on two consecutive days. Measurement error and agreement will additionally be evaluated using the standard error of measurement (SEM), minimal detectable change (MDC95), and Bland-Altman analysis.

    Time frame: Day 1 and Day 2 (two consecutive days)

Secondary outcomes

  1. Inter-rater reliability of paired quadriceps twitch force measurements

    Inter-rater reliability of paired quadriceps twitch force measurements will be assessed using the intraclass correlation coefficient (ICC) with 95% confidence intervals, comparing measurements performed by two different assessors on the second day. Measurement error and agreement will additionally be evaluated using SEM, MDC95, and Bland-Altman analysis.

    Time frame: Day 2 (morning and afternoon)

  2. Intra-rater reliability of single quadriceps twitch force measurements

    Intra-rater reliability of single quadriceps twitch force measurements will be assessed using the intraclass correlation coefficient (ICC) with 95% confidence intervals, comparing measurements performed by the same assessor on two consecutive days. Measurement error and agreement will additionally be evaluated using SEM, MDC95, and Bland-Altman analysis.

    Time frame: Day 1 and Day 2 (two consecutive days)

  3. Inter-rater reliability of single quadriceps twitch force measurements

    Inter-rater reliability of single quadriceps twitch force measurements will be assessed using the intraclass correlation coefficient (ICC) with 95% confidence intervals, comparing measurements performed by two different assessors on the second day. Measurement error and agreement will additionally be evaluated using SEM, MDC95, and Bland-Altman analysis.

    Time frame: Day 2 (morning and afternoon)

  4. Convergent validity of single twitch force with maximal voluntary contraction

    Convergent validity will be assessed by examining the association between single quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation and maximal voluntary contraction (MVC) force, using Pearson's correlation coefficient (r).

    Time frame: Day 1

  5. Convergent validity of paired twitch force with maximal voluntary contraction

    Convergent validity will be assessed by examining the association between paired quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation and maximal voluntary contraction (MVC) force, using Pearson's correlation coefficient (r).

    Time frame: Day 1

  6. Convergent validity of single twitch force with potentiated twitch force

    Convergent validity will be assessed by examining the association between single quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation and potentiated twitch force, using Pearson's correlation coefficient (r).

    Time frame: Day 1

  7. Convergent validity of paired twitch force with potentiated twitch force

    Convergent validity will be assessed by examining the association between paired quadriceps twitch force measurements obtained using magnetic femoral nerve stimulation and potentiated twitch force, using Pearson's correlation coefficient (r).

    Time frame: Day 1

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891273
Lead sponsor
Daniel Langer
Responsible party
Daniel Langer (Co-investigator, associate professor, KU Leuven) — Sponsor-investigator
First posted
Oct 23, 2026
Start date
Dec 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Daniel Langer
Contact
daniel.langer@kuleuven.be
+32 16 34 71 25

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion